Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Knockdown of hypoxia-inducible factor-1 alpha by tumor targeted delivery of CRISPR/Cas9 system suppressed the metastasis of pancreatic cancer
Man Li, Hanbing Xie, Yingke Liu, et al.
Journal of Controlled Release (2019) Vol. 304, pp. 204-215
Closed Access | Times Cited: 111

Showing 1-25 of 111 citing articles:

Chemoresistance in Pancreatic Cancer
Siyuan Zeng, Marina Pöttler, Bin Lan, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 18, pp. 4504-4504
Open Access | Times Cited: 509
Recent advancements in liposome technology
Nina Filipczak, Jiayi Pan, Satya Siva Kishan Yalamarty, et al.
Advanced Drug Delivery Reviews (2020) Vol. 156, pp. 4-22
Closed Access | Times Cited: 437
Targeting hypoxic tumor microenvironment in pancreatic cancer
Jinxin Tao, Gang Yang, Wenchuan Zhou, et al.
Journal of Hematology & Oncology (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 290
Nanotechnology-based delivery of CRISPR/Cas9 for cancer treatment
Xiaoyu Xu, Chang Liu, Yonghui Wang, et al.
Advanced Drug Delivery Reviews (2021) Vol. 176, pp. 113891-113891
Open Access | Times Cited: 183
Targeting the tumor stroma for cancer therapy
Maosen Xu, Tao Zhang, Ruolan Xia, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 168
Delivery of CRISPR/Cas systems for cancer gene therapy and immunotherapy
Xiangrong Song, Chao Liu, Ning Wang, et al.
Advanced Drug Delivery Reviews (2020) Vol. 168, pp. 158-180
Closed Access | Times Cited: 164
Rational designs of in vivo CRISPR-Cas delivery systems
Cong‐Fei Xu, Guojun Chen, Ying‐Li Luo, et al.
Advanced Drug Delivery Reviews (2019) Vol. 168, pp. 3-29
Closed Access | Times Cited: 160
Actively targeted nanomedicines for precision cancer therapy: Concept, construction, challenges and clinical translation
Wenxing Gu, Fenghua Meng, Rainer Haag, et al.
Journal of Controlled Release (2020) Vol. 329, pp. 676-695
Closed Access | Times Cited: 154
Liposome-based delivery of biological drugs
Kosheli Thapa Magar, George Frimpong Boafo, Xiaotong Li, et al.
Chinese Chemical Letters (2021) Vol. 33, Iss. 2, pp. 587-596
Closed Access | Times Cited: 128
Biomembrane-based nanostructures for cancer targeting and therapy: From synthetic liposomes to natural biomembranes and membrane-vesicles
Jing Wang, Motao Zhu, Guangjun Nie
Advanced Drug Delivery Reviews (2021) Vol. 178, pp. 113974-113974
Closed Access | Times Cited: 120
Carrier strategies boost the application of CRISPR/Cas system in gene therapy
Zunkai Xu, Qingnan Wang, Haiping Zhong, et al.
Exploration (2022) Vol. 2, Iss. 2
Open Access | Times Cited: 80
Non-viral delivery of the CRISPR/Cas system: DNAversusRNAversusRNP
Yi Lin, Ernst Wagner, Ulrich Lächelt
Biomaterials Science (2022) Vol. 10, Iss. 5, pp. 1166-1192
Open Access | Times Cited: 74
CRISPR/Cas9 systems: Delivery technologies and biomedical applications
Yimin Du, Yanfei Liu, Jiaxin Hu, et al.
Asian Journal of Pharmaceutical Sciences (2023) Vol. 18, Iss. 6, pp. 100854-100854
Open Access | Times Cited: 53
Clinical applications of the CRISPR/Cas9 genome-editing system: Delivery options and challenges in precision medicine
Mohadeseh Khoshandam, Hossein Soltaninejad, Marziyeh Mousazadeh, et al.
Genes & Diseases (2023) Vol. 11, Iss. 1, pp. 268-282
Open Access | Times Cited: 45
Current and future immunotherapeutic approaches in pancreatic cancer treatment
Pooya Farhangnia, Hossein Khorramdelazad, Hamid Nickho, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 38
Invasion and metastasis in cancer: molecular insights and therapeutic targets
Yongxing Li, Fengshuo Liu, Qingjin Cai, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 3
For and against tumor microenvironment: Nanoparticle-based strategies for active cancer therapy
Soroush Karimi, Roksana Bakhshali, Soheil Bolandi, et al.
Materials Today Bio (2025) Vol. 31, pp. 101626-101626
Open Access | Times Cited: 3
Peptide-Based Drug Delivery Systems
Dmitriy Berillo, Adilkhan Yeskendir, Zharylkasyn Zharkinbekov, et al.
Medicina (2021) Vol. 57, Iss. 11, pp. 1209-1209
Open Access | Times Cited: 79
The in vivo fate and targeting engineering of crossover vesicle-based gene delivery system
Xinchi Jiang, Tianyuan Zhang, Jianqing Gao
Advanced Drug Delivery Reviews (2022) Vol. 187, pp. 114324-114324
Closed Access | Times Cited: 48
Nanoparticle-based therapeutic strategies targeting major clinical challenges in pancreatic cancer treatment
Mubin Tarannum, Juan L. Vivero‐Escoto
Advanced Drug Delivery Reviews (2022) Vol. 187, pp. 114357-114357
Open Access | Times Cited: 42
The bioengineered and multifunctional nanoparticles in pancreatic cancer therapy: Bioresponisive nanostructures, phototherapy and targeted drug delivery
Mohamed J. Saadh, Hala Baher, Yuanji Li, et al.
Environmental Research (2023) Vol. 233, pp. 116490-116490
Closed Access | Times Cited: 32
Engineered Nanomaterials to Potentiate CRISPR/Cas9 Gene Editing for Cancer Therapy
Ke Yi, Huimin Kong, Yeh‐Hsing Lao, et al.
Advanced Materials (2023) Vol. 36, Iss. 13
Closed Access | Times Cited: 30
Nanotechnology‐based CRISPR/Cas9 delivery system for genome editing in cancer treatment
Shiyao Zhou, Yingjie Li, Qinjie Wu, et al.
MedComm – Biomaterials and Applications (2024) Vol. 3, Iss. 1
Open Access | Times Cited: 11
Advances in liposome-based delivery of RNA therapeutics for cancer treatment
Mehdi Sanati, Amir R. Afshari, Seyed Sajad Ahmadi, et al.
Progress in molecular biology and translational science (2024), pp. 177-218
Closed Access | Times Cited: 10
Polymeric micellar nanoparticles for effective CRISPR/Cas9 genome editing in cancer
Yuzhen Li, Chun Li, Jiachang Yan, et al.
Biomaterials (2024) Vol. 309, pp. 122573-122573
Closed Access | Times Cited: 10
Page 1 - Next Page

Scroll to top